Cite

HARVARD Citation

    Watanabe, S. et al. (2016). The usefulness of 18F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC cancer. 16 (1), pp. 1-8. [Online]. 
  
Back to record